1. Home
  2. COUR vs IOVA Comparison

COUR vs IOVA Comparison

Compare COUR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$5.53

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.99

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COUR
IOVA
Founded
2012
2007
Country
United States
United States
Employees
1307
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
COUR
IOVA
Price
$5.53
$4.99
Analyst Decision
Buy
Buy
Analyst Count
15
10
Target Price
$10.53
$9.00
AVG Volume (30 Days)
7.3M
13.6M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
39.22
14.84
EPS
N/A
N/A
Revenue
$757,500,000.00
N/A
Revenue This Year
$9.43
$47.74
Revenue Next Year
$6.40
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
9.04
N/A
52 Week Low
$5.00
$1.76
52 Week High
$13.56
$5.63

Technical Indicators

Market Signals
Indicator
COUR
IOVA
Relative Strength Index (RSI) 46.99 64.61
Support Level $5.48 $2.08
Resistance Level $6.33 $5.63
Average True Range (ATR) 0.25 0.39
MACD -0.03 0.06
Stochastic Oscillator 16.72 90.15

Price Performance

Historical Comparison
COUR
IOVA

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: